During the past decade, Eastern Nephrology Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eastern Nephrology Associates" #1 sponsor was "Pfizer" with 3 trials, followed by "Saint Luke's Health System" with 2 trials sponsored, "Shire" with 2 trials sponsored, "Anji Pharma" with 1 trials sponsored and "Apellis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastern Nephrology Associates" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Eastern Nephrology Associates" are "Cardiovascular Disease" (3 trials), "End Stage Renal Disease" (3 trials), "Atrial Fibrillation" (1 trials), "C3 Glomerulonephritis" (1 trials) and "Chronic Heart Failure With Preserved Systolic Function" (1 trials). Many other conditions were trialed in "Eastern Nephrology Associates" in a lesser frequency.

Most popular intervention types in "Eastern Nephrology Associates" are "Drug" (11 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dapagliflozin matching placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "APL-2" (1 trials) and "Conventional Split-tip Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eastern Nephrology Associates" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Eastern Nephrology Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Eastern Nephrology Associates, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Eastern Nephrology Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".